Oxaliplatin Recruiting Phase 3 Trials for Adenocarcinomas of the Gastroesophageal Junction Treatment

IndicationsStatusPurposePhase
RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT04375605Neoadjuvant RCT Versus CT for Patients With Locally Advanced, Potentially Resectable Adenocarcinoma of the GEJ
NCT03986385Apatinib Plus Concurrent Neoadjuvant Chemoradiotherapy for Gastroesophageal Junction